In some cases, it may actually be more beneficial for this group of women to forego the extra scans, as they can lead to additional testing, costs and potentially delays in care.
The Raleigh, North Carolina-based company—which formerly went by US Radiology Specialists—is offering 25 million shares of common stock at $18.50 apiece.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.